[Endothelium as a target for new therapeutic strategies in cerebral vascular diseases]

Area of Science:

• Vascular Biology
• Neurology
• Cardiology

Background:

• Endothelial dysfunction is implicated in the pathogenesis of cerebral vascular diseases (CVD).
• Understanding the endothelium's role is crucial for preventing and treating CVD.
• Pathological processes leading to CVD often involve endothelial dysfunction.

Purpose of the Study:

• To evaluate the role of the endothelium in the development of CVD.
• To explore the concept of using endothelial function as a target for CVD prevention and treatment.
• To outline current medical strategies for correcting endothelial dysfunction in CVD.

Main Methods:

• Literature review and conceptual analysis of endothelial function in CVD.
• Evaluation of existing medical strategies for managing endothelial dysfunction.
• Categorization of therapeutic approaches into tactical and strategic interventions.

Main Results:

• The endothelium is a critical factor in the pathogenesis of CVD.
• Two primary medical strategies exist for correcting endothelial dysfunction: tactical (antioxidants) and strategic (statins, hypotensive drugs, antiaggregants).
• These strategies aim to prevent or treat pathological processes contributing to CVD.

Conclusions:

• Targeting endothelial function offers a promising avenue for CVD prevention and treatment.
• Antioxidants represent a tactical approach, while statins, hypotensive drugs, and antiaggregants form a strategic approach.
• Further research into endothelial health is vital for advancing CVD management.